chr1-8656247-T-TCGGTCC
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2
The NM_001042681.2(RERE):c.45_50dupGGACCG(p.Arg17_Asp18insAspArg) variant causes a disruptive inframe insertion change. The variant allele was found at a frequency of 0.00874 in 1,613,208 control chromosomes in the GnomAD database, including 81 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0063 ( 4 hom., cov: 31)
Exomes 𝑓: 0.0090 ( 77 hom. )
Consequence
RERE
NM_001042681.2 disruptive_inframe_insertion
NM_001042681.2 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.80
Publications
0 publications found
Genes affected
RERE (HGNC:9965): (arginine-glutamic acid dipeptide repeats) This gene encodes a member of the atrophin family of arginine-glutamic acid (RE) dipeptide repeat-containing proteins. The encoded protein co-localizes with a transcription factor in the nucleus, and its overexpression triggers apoptosis. A similar protein in mouse associates with histone deacetylase and is thought to function as a transcriptional co-repressor during embryonic development. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
RERE Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorder with or without congenital anomaliesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorder with or without anomalies of the brain, eye, or heartInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_001042681.2.
BP6
Variant 1-8656247-T-TCGGTCC is Benign according to our data. Variant chr1-8656247-T-TCGGTCC is described in ClinVar as Benign. ClinVar VariationId is 377359.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00628 (955/152186) while in subpopulation NFE AF = 0.00947 (644/67990). AF 95% confidence interval is 0.00887. There are 4 homozygotes in GnomAd4. There are 482 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 955 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RERE | NM_001042681.2 | c.45_50dupGGACCG | p.Arg17_Asp18insAspArg | disruptive_inframe_insertion | Exon 2 of 23 | ENST00000400908.7 | NP_001036146.1 | |
| RERE | NM_012102.4 | c.45_50dupGGACCG | p.Arg17_Asp18insAspArg | disruptive_inframe_insertion | Exon 3 of 24 | NP_036234.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RERE | ENST00000400908.7 | c.45_50dupGGACCG | p.Arg17_Asp18insAspArg | disruptive_inframe_insertion | Exon 2 of 23 | 1 | NM_001042681.2 | ENSP00000383700.2 |
Frequencies
GnomAD3 genomes AF: 0.00627 AC: 954AN: 152068Hom.: 4 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
954
AN:
152068
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00641 AC: 1607AN: 250740 AF XY: 0.00664 show subpopulations
GnomAD2 exomes
AF:
AC:
1607
AN:
250740
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00900 AC: 13149AN: 1461022Hom.: 77 Cov.: 31 AF XY: 0.00895 AC XY: 6504AN XY: 726892 show subpopulations
GnomAD4 exome
AF:
AC:
13149
AN:
1461022
Hom.:
Cov.:
31
AF XY:
AC XY:
6504
AN XY:
726892
show subpopulations
African (AFR)
AF:
AC:
39
AN:
33458
American (AMR)
AF:
AC:
86
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
AC:
30
AN:
26124
East Asian (EAS)
AF:
AC:
0
AN:
39688
South Asian (SAS)
AF:
AC:
264
AN:
86238
European-Finnish (FIN)
AF:
AC:
943
AN:
53420
Middle Eastern (MID)
AF:
AC:
21
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
11323
AN:
1111252
Other (OTH)
AF:
AC:
443
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
659
1318
1976
2635
3294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
424
848
1272
1696
2120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00628 AC: 955AN: 152186Hom.: 4 Cov.: 31 AF XY: 0.00648 AC XY: 482AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
955
AN:
152186
Hom.:
Cov.:
31
AF XY:
AC XY:
482
AN XY:
74406
show subpopulations
African (AFR)
AF:
AC:
55
AN:
41548
American (AMR)
AF:
AC:
23
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5170
South Asian (SAS)
AF:
AC:
16
AN:
4820
European-Finnish (FIN)
AF:
AC:
202
AN:
10616
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
644
AN:
67990
Other (OTH)
AF:
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
49
98
148
197
246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 07, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
RERE: BS1, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.